Skip to main content

Marketing

Behavioral Healthcare Executive
Baltimore County, Md., is increasing public awareness of the opioid crisis by displaying signs depicting total and fatal overdoses.
Marketing
Christian De Oliveira, chief operating officer for Transcend Recovery Community, explains how his company has refined its marketing strategies, used messages of positivity, and diversified its tactics to continually reach its target audience.
Marketing
Paul Gomez, principal and chair of Polsinelli Behavioral Health Law Group, says providers should take a close look at their marketing arrangements in light of recently passed laws such as the Eliminating Kickbacks in Recovery Act.
Marketing
Months after Google, Facebook and, more recently, Bing began requiring addiction treatment centers to obtain certification to advertise, problematic ads are still appearing and providers wonder if the process has been worth it.
Marketing
LeShaundra Cordier, MPH, CHES, communications team lead for the CDC, and Christina Zurla, partner with the strategic consulting and communications firm ICF, share ideas and advice for crafting and delivering effective opioid related messages.
Marketing
Treatment centers run the risk of violating kickback laws by hosting improper professional education events. William P. Hoffman, shareholder for the Polsinelli law firm, recommends a series of steps to limit legal exposure.
Marketing
A pair of lead aggregation websites recently soared to the top of Google’s organic search results for popular addiction treatment terms, setting off alarm bells among ethical operators.
Treatment
Along with their children and family dog, advocates Robyn Cruze and Tim Harrington are embarking on a coast-to-coast tour to support individuals struggling with substance use disorders and mental illness.
Marketing
The Certified Admissions and Marketing Specialist credential will give providers a new way to signal they are operating in an above-board manner.
Business Strategy
Kaleo CEO Spencer Williamson told CBS’s “60 Minutes” his company would drop the price of the Evzio naloxone auto-injector if insurers and pharmacy benefit managers stop blocking access to it.
Back to Top